Displaying 11–20 of 377 diseases results
Sep 7, 2023
Opus was established by the RD Fund, the Foundation’s venture philanthropy arm
Sep 6, 2023
The free, online event will feature a lecture from David Boyer, MD, a Senior Partner at Retina-Vitreous Associates Medical Group and dry AMD expert.
Aug 31, 2023
First cohort of patients has been dosed in Phase ½ clinical trial taking place in Pittsburgh and Paris
Aug 28, 2023
The AAV.SPR gene delivery system used in the trial is designed to more safely reach targeted retinal cells
Aug 22, 2023
New, higher treatment dose reduces frequency of eye injections for patients
Aug 21, 2023
At a mere 15 years old, Ava Ruggiero’s world shifted when she received a diagnosis of retinitis pigmentosa. As Ava continues to find balance as a student and athlete, she discusses the challenges of navigating her diagnosis alongside her parents, Joseph and Stephanie.
Aug 5, 2023
In two Phase 3 clinical trials, IZERVAY slowed the growth rate of lesions, the regions of cell loss in the central retina, associated with geographic atrophy (GA)
Jul 28, 2023
The company’s emerging, oral treatment is designed to slow vision loss
Jul 24, 2023
Chloé Duplessis is a legally blind digital collage artist in Denver, Colorado. At 39 years old, Chloé was diagnosed with Stargardt disease, which was a pivotal point in her creative journey to becoming a full-time artist and owner of Duplessis Art.
Jul 12, 2023
The emerging RNA therapy is designed to boost expression of the PRPF31 protein